Ultra-low distortion and noise electronics to enable a clinical MPI imaging platform
Ultra-low distortion and noise electronics to enable a clinical MPI imaging platform
批准号:
10761613
负责人:
Patrick Goodwill
金额:
$100.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-22 至 2025-07-31
关键词:
AirAmplifiersAnatomyAnimalsApplications GrantsAreaBrainCategoriesCell TherapyCellsClassificationClimactericClinicalClinical TreatmentComplexCouplingDevelopmentDiagnosisDiscipline of Nuclear MedicineDiseaseElectric CapacitanceElectronicsEngineeringFloorFunctional ImagingGoalsGrantHalf-LifeHemorrhageHemosiderinHumanImageImaging TechniquesImaging technologyInflammationInfrastructureInstitutionInternationalMagnetic Resonance ImagingMagnetic nanoparticlesMagnetismMarketingMeasurementMeasuresMedical ImagingMedicineModalityModernizationMolecularMonitorNoisePathologyPerformancePhasePhysicsPhysiologic pulsePhysiologicalPositron-Emission TomographyPre-Clinical ModelRadioactiveRadioactive TracersResolutionRoentgen RaysRoleSafetyScientistShippingSignal TransductionSmall Business Innovation Research GrantSpeedStructureSystemTechniquesTechnologyTestingTissuesTracerVisualizationWorkcellular imagingclinical diagnosisclinical imagingcommercializationcontrast imagingdesignhuman imagingimagerimaging modalityimaging platformimaging systemimprovedinnovationinsightinstrumentmagnetic fieldnanonew technologynuclear imagingparticlepre-clinicalprototyperesearch clinical testingsingle photon emission computed tomographystem cellstooltransmission processultrasoundvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT
In this SBIR grant proposal, “Ultra-low distortion and noise electronics to enable a clinical MPI imaging platform,”
we will develop the RF subsystem for a clinical magnetic particle imaging (MPI) platform to enable three classes
of MPI applications: cell tracking, functional imaging, and endogenous contrast imaging. Our overall approach is
to improve sensitivity and resolution by minimizing distortion, adding transmit/receive channels, decoupling,
improving preamplifiers, and developing new pulse sequences.
MPI is an emerging molecular and tracer imaging technology that directly detects magnetic nanoparticles
(MNPs) with high sensitivity at mm-scale resolutions. MPI images are direct views of tracer distribution with no
signal arising from tissue, no perturbations from materials such as air, and image intensity directly linear with
tracer concentration. This “hot-spot” contrast provides spatial localization and quantification without ambiguity.
MPI’s contrast is similar to nuclear medicine but without the workflow, safety, and half-life limitations of a
radioactive tracer. MPI has many applications in the brain and body, as demonstrated by our customers in small
animals. Despite significant efforts by multiple institutions, the lack of a clinical MPI scanner remains a significant
limitation for the technique.
In this Direct to Phase II SBIR proposal, we will advance the medical imaging field by building the world’s
first general-purpose clinical MPI scanner to serve the myriad applications our customers are testing on our
preclinical instrument. We will design and implement a new transmit/receive subsystem and install it in our
prototype scanner to achieve the performance necessary for clinical imaging applications. This new
transmit/receive subsystem includes the following innovations that push our sensitivity from our current rough
prototype to near the physics limit through the following specific aims:
Aim 1. Drive transmit distortion and the noise floor to the physics limit for a one-channel Tx/Rx coil
Aim 2. Design a clinical multi-channel transmit and receive subsystem
Aim 3. Develop new acquisition pulse sequences to improve sensitivity, resolution, and speed
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a prototype clinical theranostic platform combining Magnetic Particle Imaging (MPI) and Magnetic Fluid Hyperthermia (MFH) for the treatment of brain tumors
-
批准号:10761630
-
项目类别:
-
资助金额:$101.17万
-
财政年份:2023
-
负责人:Patrick Goodwill
-
依托单位:
Color MPI as a novel method for in vivo assessment of magnetic nanoparticle dynamics and binding
-
批准号:10010333
-
项目类别:
-
资助金额:$80.99万
-
财政年份:2020
-
负责人:Patrick Goodwill
-
依托单位:
Color MPI as a novel method for in vivo assessment of magnetic nanoparticle dynamics and binding
-
批准号:10249102
-
项目类别:
-
资助金额:$80.24万
-
财政年份:2020
-
负责人:Patrick Goodwill
-
依托单位:
Development of a Neurovascular Magnetic Particle Imaging system with sub-millimeter resolution and real time speed for non-radiative 3D perfusion angiography
-
批准号:9049379
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2015
-
负责人:Patrick Goodwill
-
依托单位:
Phase II: Commercialization of a preclinical Magnetic Particle Imaging system with sub-millimeter resolution, nano-molar sensitivity, and integrated CT
-
批准号:9752545
-
项目类别:
-
资助金额:$73.07万
-
财政年份:2015
-
负责人:Patrick Goodwill
-
依托单位:
海外基金